好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2004 Annual Meeting | Common and Uncommon Phenotypes in Neuromuscular Disease

Sunday 04/25/04
06:00 PM - 09:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Dinner Seminar
Jonathan S. Katz, MD
Neuromuscular and Clinical Neurophysiology (EMG)
Upon completion:
Participants should be able to recognize several common and uncommon neuromuscular phenotypes. They should recognize the importance of the clinical bedside examination in making diagnoses and how to avoid pitfalls of diagnostic testing in the areas of myopathies, neuropathies, neuromuscular disorders, and motor neuron disorders.
No CME available
Introductory
Practitioner, Fellow, Academician, Resident
Event Timeline
06:00 PM - 06:45 PM Neuropathy Phenotypes: Finding Treatment Responsive Cases (CIDP, MADSAM, Sensory CIDP, DADS)
Jonathan S. Katz, MD
06:45 PM - 07:30 PM Myopathy Phenotypes: IBM, Dermatomyositis, Dystrophies, and Does Polymyositis Exist?
Anthony A. Amato, MD, FAAN
07:30 PM - 08:15 PM Working Up the Pure Motor Presentations (ALS, PMA, SMA, MAMA, BAD, MMN, etc.)
David S. Saperstein, MD
08:15 PM - 09:00 PM Neuromuscular Junction Phenotypes (LEMS, MuSK, and the Many Faces of MG)
Richard J. Barohn, MD, FAAN
Faculty Disclosures
Richard J. Barohn, MD, FAAN Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Anthony A. Amato, MD, FAAN Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abscuro. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Caballeta. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Amato has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian Therapeutics. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medpace. Dr. Amato has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for legal firms. The institution of Dr. Amato has received research support from NIH. Dr. Amato has received publishing royalties from a publication relating to health care.
Jonathan S. Katz, MD Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Calico. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenyx. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Katz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Griffols. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
David S. Saperstein, MD No disclosure on file